Skip to main content

Table 2 Initial and final follow-up comparison of non-concurrent cohort according to groups (hypertensive diabetics and non-diabetics) in laboratory and clinical parameters, Goiânia, GO, Brazil, 2004–2015

From: Hypertensive diabetic patients: incidence of cardiovascular and renal outcomes in a historical cohort over 11 years

 

Diabetic hypertensive (n = 55)

Non-diabetic hypertensive (n = 84)

2004

2015

p**

2004

2015

p**

Median

Median

Median

Median

(95% CI)

(95% CI)

(95% CI)

(95% CI)

SBP

139.0 (132.0–143.0)

134.0 (133.0–143.8)

0.586

130.7 (129.4–138.2)

131.0 (129.5–136.8)

0.742

DBP

85.0 (81.9–89.8)

73.0 (71.8–77.8)

< 0.001

82.0 (81.7–87.4)

73.7 (71.8–76.3)

< 0.001

BMI

29.3 (29.5–32.5)

29.3 (28.9–32.1)

0.080

26.3 (25.8–27.6)

27.1 (26.1–28.1)

0.081

GFR

139.0 (136.1–167.5)

139.0 (129.8–167.5)

0.891

96.0 (92.2–99.5)

93.0 (91.5–98.1)

0.655

TC

215.0 (200.9–229.8)

165.0 (157.2–184.8)

< 0.001

201.5 (198.3–218.1)

181.6 (175.4–188.8)

< 0.001

HDL

47.0 (43.6–51.5)

51.0 (49.2–56.2)

0.009

47.0 (45.0–50.3)

48.0 (45.7–51.2)

0.056

LDL

126.0 (111.5–197.3)

85.3 (80.4–95.3)

< 0.001

129.5 (125.3–141.2)

112.0 (103.2–115.1)

< 0.001

TG

179.0 (169.4–257.1)

134.0 (117.3–249.8)

0.024

110.5 (119.5–163.7)

114.0 (113.9–140.9)

0.825

CC

82.9 (76.7–87.7)

64.2 (62.2–79.1)

< 0.001

70.2 (70.5–80.2)

61.9 (60.3–71.7)

< 0.001

HbA1c

9.2 (5.0–15.0)

7.4 (5.5–13.3)

0.002

  1. BMI body mass index, SBP systolic blood pressure, DBP diastolic blood pressure, GFR glomerular filtration rate, TC total cholesterol, HDL HDL cholesterol, LDL LDL cholesterol, TG triglycerides, CC creatinine clearance, HbA1c hemoglobin, 95% CI 95% confidence interval
  2. ** Mann–Whitney U test